Cited by 49Treatment of Major DepressionDementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments

Similarities Between Depression and Neurodegenerative Diseases: Pathophysiology, Challenges in Diagnosis and Treatment Options

Open access
Hussain, Madiha, Kumar, Prabhat, Khan, Sara, Gordon, Domonick K, Khan, Safeera·2020·Cureus

Abstract

Depressive disorder and neurodegenerative diseases are two different clinical entities. Depression is a common psychiatric disorder in the general population. However, when present concomitantly with neurodegenerative disorders, its diagnosis becomes challenging. In many cases, patients remain undiagnosed and hence, untreated, worsening the prognosis of the neurodegenerative diseases and impairing the quality of life. One of the possible reasons for the difficulties in diagnosis in such cases is that both conditions affect the central nervous system, so there might be an overlap of symptoms leading to a missed diagnosis of depression in a neurodegenerative disease patient and vice versa. Symptoms such as irritability, apathy, and decreased cognition are common to both types of disorders. Some neurodegenerative diseases, especially Alzheimer's disease, can initially present as a depressive prodrome. This may cause a difficulty in differentiating between these two conditions and a diagnosis of either conditions may be missed; hence an opportunity for timely intervention and improved outcomes is missed. An approach towards analyzing and comparing the pathological mechanisms common to both disease types will create a better understanding of depression and neurodegenerative diseases, identify their similarities, and develop improved clinical criteria to help clinicians make a timely diagnosis of these conditions present together. In the present review, various studies related to common pathological links, concomitant diagnosis challenges, and ongoing research about different treatment options are discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7759/cureus.11613

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clinicians face considerable difficulties identifying and differentiating between similar conditions, especially when symptoms frequently appear across many common diseases.

    “Clinicians face considerable difficulties identifying and differentiating between similar conditions, especially when symptoms frequently appear across many common diseases [124,125].”

    From Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors (2026) · cites this paper as [124]

    The Introduction and background says that overlapping symptoms make differential diagnosis challenging for depression and neurodegenerative diseases. The claim extends this difficulty to symptoms appearing across many common diseases, a broader scope the paper does not establish. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 31 · Cited by 49

Research works printed but not linked: 28

  1. [1]Depression is the leading cause of disability worldwide JAMA Freidrich MJ 1517 317 2017 28418490
  2. [2]Depressive symptoms in neurodegenerative diseases World J Clin Cases Baquero M Martín N 682 693 3 2015 26301229 PMC4539408
  3. [3]Biomarkers for major depression and its delineation from neurodegenerative disorders Prog Neurobiol Schneider B Prvulovic D Oertel-Knochel V 703 717 95 2011 21854829
  4. [4]Neurochemical correlation between major depressive disorder and neurodegenerative diseases Life Sci Reus GZ Titus SE Abelaira HM Freitas SM Tuan T Quevedo J Budni J 121 129 158 2016 27370938
  5. [5]Monoamine oxidase inhibitors and iron chelators in depressive illness and neurodegenerative disorders J Neural Transm (Vienna) Youdim MBH 1719 1733 125 2018 30341696
  6. [6]Depression and dementia Psychol Neuropsychiatr Vieil Derouesne C Lacomblez L 35 42 2 2004 15899643
  7. [7]Depression associated with dementia Z Gerontol Geriatr Gutzmann H Qazi A 305 311 48 2015 25962363
  8. [8]Drug treatment strategies for depression in Parkinson's disease Expert Opin Pharmacother Ryan M Eatman CV Slevin JT 1351 1363 20 2019 31120798
  9. [9]Neuroinflammation, neurodegeneration and depression Neurotox Res Hurley LL Tizabi Y 131 144 23 2013 22895696 PMC3751583
  10. [11]Depression in neurodegenerative diseases: common mechanisms and current treatment options J Neurosci Biohav Rev Galts CPC Bettio LEB Jewett DC 56 84 102 2019 30995512
  11. [12]Differential roles of M1 and M2 microglia in neurodegenerative diseases Mol Neurobiol Tang Y Le W 1181 1194 53 2016 25598354
  12. [13]Therapeutic role and drug delivery potential of neuroinflammation as a target in neurodegenerative disorders ACS Chem Neurosci Singh A Chokriwal A Sharma MM Jain D Saxena J Stephen BJ 1645 1655 8 2017 28719178
  13. [14]Structure-based specific detection and inhibition of monoamine oxidases and their application in central nervous system diseases ChemBiochem Shi R Wu Q Xin C 1487 1497 20 2019 30664830
  14. [15]Stress-induced neural reorganization: a conceptual framework linking depression and Alzheimer's disease Prog Neuropsychopharmacol Biol Psychiatry Ross JA Gleibus G Bockstaele EJ 136 151 85 2018 28803923 PMC5809232
  15. [16]Distinguishing between depression and dementia in older persons: Neuropsychological and Neuropathological correlates J Geriatr Psychiatry Neurol Wright SL Persad C 189 198 20 2007 18004006
  16. [17]The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease J Clin Psychiatry Woolley JD Khan BK Murthy NK Miller BL Rankin KP 126 133 72 2011 21382304 PMC3076589
  17. [18]Depressive disorders in dementia and mild cognitive impairments: Is comorbidity a cause or a risk factor? Fortschr Neurol Psychiatr Preuss UW Siafarikas N Pettrucci M Wong WM 399 406 77 2009 19533574
  18. [19]Comorbid depression in dementia on psychogeriatric nursing home wards: which symptoms are prominent? Am J Geriatr Psychiatry Verkaik R Francke AL van Meijel B Ribbe MW Bensing JM 565 573 17 2009 19554671
  19. [20]Phenomenology of depression in Alzheimer's disease J Alzheimers Dis Novais F Starkstein S 845 855 47 2015 26401763
  20. [21]Cognitive impairments and depression in Parkinson's disease: a follow-up study J Neurol Neurosurg Psychiatry Starkstein SE Bolduc PL Mayberg HS Preziosi TJ Robinson RG 597 602 53 1990 2391525 PMC488137
  21. [22]Depression in neurological disorders: an update Curr Opin Psychiatry Rickards H 294 298 19 2006 16612216
  22. [23]Depression and the risk of dementia Curr Opin Psychiatry Kessing LV 457 461 25 2012 22801361
  23. [24]Depression-dementia medius: between depression and the manifestations of dementia symptoms Psychogeriatrics Kobayashi T Kato S 177 182 11 2011 21951959
  24. [25]Efficacy of antidepressants for depression in Alzheimer's disease; systematic review and meta-analysis J Alzheimers Dis Orgeta V Tabet N Nilforooshan R Howard R 725 733 58 2017 28505970 PMC5467718
  25. [27]Role of calcium, glutamate and NMDA in major depression and therapeutic application Prog Neuropsychopharmacol Biol Psychiatry Deutschenbaur L Beck J Kiyhankhadiv A 325 333 64 2016 25747801
  26. [28]Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment Curr Drug Targets Weinreb O Amit T Bar-Am O Youdim MH 483 494 13 2012 22280345
  27. [29]A review on the oxidative and nitrosative stress (O & NS) pathways in major depression and their possible contribution to neurodegenerative processes in that illness Prog Neuropsychopharmacol Biol Psychiatry Maes M Galecki P Chang YS Berk M 676 692 35 2011 20471444
  28. [30]Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update Psychopharmacol Bull Pomara N Greenberg WM Branford MD Doraiswamy PM 120 134 37 2003 https://pubmed.ncbi.nlm.nih.gov/14674372/ 14674372

Authors
Hussain, M., Kumar, P., Khan, S., Gordon, D. K., & Khan, S.
Affiliations
Cleveland Clinic (US)
Corresponding author
Hussain, Madiha
Venue
Cureus
Published
2020-11-21
Volume
12
Issue
11
Pages
e11613-e11613
ISSN
2168-8184 (ISSN-L)
OpenAlex
W3110054015
Cited by
49
References
31
Citations by year
2026: 2 · 2025: 9 · 2024: 12 · 2023: 14 · 2022: 8 · 2021: 4
FWCI
0.85
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Cureus (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
depression, neurodegenerative diseases, Alzheimer's disease, comorbidities, differential diagnosis, pathophysiology, cognitive impairment, irritability, apathy, treatment options, missed diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review